FRRS1 operates as a ferric-chelate reductase, primarily reducing Fe³⁺ to Fe²⁺ for cellular uptake . Key roles include:
Iron Homeostasis: Facilitates endosomal iron transport by converting transferrin-bound Fe³⁺ to Fe²⁺, which is then exported to the cytoplasm via divalent metal transporter 1 (DMT1) .
Antioxidant Role: Regulates reactive oxygen species (ROS) by maintaining ascorbic acid levels, which scavenge free radicals .
Pathological Implications: Modulates ferroptosis—a iron-dependent cell death pathway—by influencing glutathione peroxidase 4 (GPX4) and lipid peroxidation .
Ferroptosis Inhibition: Overexpression of FRRS1 in intestinal ischemia models reduced iron accumulation, ROS production, and inflammatory responses. It upregulated GPX4 (an antioxidant enzyme) while suppressing ACSL4 (a pro-ferroptotic protein) .
Cancer Associations:
Neurodegenerative Disease: Predicted to be a risk gene for Alzheimer’s disease due to upregulated expression in affected brain tissue .
FRRS1 interacts with the Hippo signaling pathway (LATS1/YAP/TAZ axis), which regulates cell proliferation and death. Its overexpression inhibits Hippo signaling, suggesting a protective role against tissue damage .
Therapeutic Target: Potential for treating iron dysregulation disorders (e.g., anemia, neurodegenerative diseases) and cancers reliant on iron metabolism .
Tool for Ferroptosis Studies: Used to investigate iron-dependent cell death pathways and screen inhibitors .
Drug Interaction Studies: Sensitivity to environmental toxins (e.g., aflatoxin B1, sodium arsenite) has been documented, highlighting its role in toxicology .
Recombinant Bovine FRRS1 (Ferric-Chelate Reductase 1) is a protein involved in iron metabolism. While FRRS1L (Ferric Chelate Reductase 1 Like protein) has been extensively studied in neuronal contexts, showing associations with AMPA receptors (AMPARs) in the brain, FRRS1 represents the primary functional form. Both proteins share structural similarities but may have evolved distinct functions across different species and tissues. FRRS1L has been shown to interact with both GluA1 and GluA2 subunits of AMPARs in heterologous cells and mouse neurons, suggesting potential roles in receptor trafficking and function .
Based on experimental approaches with related proteins, human embryonic kidney 293T (HEK) cells have been successfully used for expression of FRRS1L constructs. For recombinant bovine FRRS1, similar mammalian expression systems would likely be appropriate. The methodology typically involves transfection with expression vectors containing the protein of interest using reagents such as effectene transfection reagent. For optimal results, expression should be verified 48 hours post-transfection through Western blotting with appropriate antibodies .
Detection methods for FRRS1 proteins typically involve epitope tagging strategies or specific antibodies. Common approaches include:
N-terminal tagging after the signal peptide sequence (e.g., HA tag)
C-terminal tagging (e.g., Myc tag)
Immunoblotting with specific antibodies
For immunoblotting, samples are typically resolved by SDS-PAGE using 10% precast gels and then subjected to detection with appropriate antibodies. For tagged constructs, commercially available anti-tag antibodies (anti-HA, anti-Flag, anti-Myc) at 1:1,000 dilution have proven effective in previous studies of FRRS1L .
Co-immunoprecipitation (Co-IP) assays provide a robust method for examining FRRS1 protein interactions. The methodology based on FRRS1L studies would include:
Co-transfection of tagged FRRS1 and potential interacting proteins in heterologous cells (HEK cells)
Cell lysis in buffer containing 25 mM Tris (pH 7.4), 1% Triton X-100, 150 mM NaCl, 5% glycerol, 1 mM EDTA, and EDTA-free protease inhibitors
Incubation of equal amounts of cell lysate with appropriate affinity beads (e.g., anti-Flag M2)
Washing steps (three times with 300 μl lysis buffer)
Elution and analysis by SDS-PAGE followed by immunoblotting
This approach has successfully demonstrated that FRRS1L interacts with both GluA1 and GluA2 subunits of AMPARs, suggesting similar techniques could be applied to identify bovine FRRS1 interaction partners .
Subcellular localization studies of FRRS1 can be approached using fractionation techniques and immunofluorescence microscopy. Based on methodologies used for FRRS1L:
Subcellular Fractionation:
Tissue homogenization in non-detergent buffer (250 mM sucrose, 1 mM EDTA, 10 mM Tris-HCl buffer pH 7.2, protease inhibitors)
Brief sonication with two 10-s pulses
Centrifugation at 1,000 × g for 10 min to remove nuclei
Ultracentrifugation of the post-nuclear supernatant at 100,000 × g (2 hours, 4°C)
Membrane fraction isolation and analysis by Western blotting
Immunofluorescence:
Fixation of cells or tissue sections with appropriate fixatives
Permeabilization with 0.2% Triton X-100
Blocking with 5% normal goat serum
Primary antibody incubation at 4°C overnight
Secondary antibody labeling and confocal microscopy
In FRRS1L studies, researchers found that the protein partially co-localizes with GluA1 and primarily localizes at non-synaptic membranes, providing a methodological framework for similar investigations with bovine FRRS1 .
CRISPR/Cas9-mediated gene editing has been successfully applied to study FRRS1L function and could be adapted for bovine FRRS1 research. The methodology includes:
sgRNA design targeting specific exons of the FRRS1 gene
Cloning sgRNAs into appropriate vectors (e.g., pspCas9(bb)-2A-IRES-GFP)
Transfection of target cells with CRISPR constructs
Verification of knockout efficiency via Western blotting or sequencing
Functional assessment of knockout effects
For in vivo applications, studies have demonstrated embryonic electroporation techniques where FRRS1L sgRNA plasmids were injected into embryonic ventricles followed by voltage application to target neural progenitors .
Based on protocols for related proteins, FRRS1 stability can be maintained through careful buffer formulation and handling:
Homogenization buffers should contain protease inhibitors (1 tablet/10 ml, EDTA-free)
Samples should be kept on ice throughout preparation
For immunoprecipitation, use lysis buffer containing 25 mM Tris (pH 7.4), 1% Triton X-100, 150 mM NaCl, 5% glycerol, 1 mM EDTA
Storage at -80°C in aliquots to minimize freeze-thaw cycles
Addition of reducing agents (e.g., β-mercaptoethanol) in loading buffers for SDS-PAGE
These conditions have been effective in maintaining protein integrity during biochemical analysis of FRRS1L and would likely be applicable to bovine FRRS1 .
Quantitative analysis of FRRS1 expression can be performed using:
Western blotting with densitometry:
Equal protein loading determined by BCA protein assay
Normalization to housekeeping proteins (e.g., α-tubulin at 1:5000 dilution)
ImageJ software for densitometric analysis
Immunofluorescence quantification:
Maximal projection images from 4-6 serial optical sections
Background subtraction with consistent threshold values
Measurement of integrated fluorescence intensity
Region of interest (ROI) definition along relevant cellular structures
Calculation of average fluorescence intensity (total intensity divided by area)
These approaches allow for reliable quantitative comparison between experimental conditions, as demonstrated in FRRS1L studies .
While the search results don't specifically address bovine FRRS1 functional assays, approaches used for FRRS1L could be adapted:
Gain-of-function studies:
Overexpression in relevant cell types followed by functional readouts
Assessment of effects on interacting proteins or pathways
Loss-of-function studies:
Single-cell knockout approaches
Analysis of effects on partner protein expression and localization
In FRRS1L studies, researchers found that knockout significantly reduced GluA1 expression at the neuronal surface and decreased AMPAR-mediated synaptic transmission, while overexpression did not significantly change glutamatergic synaptic transmission .
While specific information about FRRS1 phosphorylation is not provided in the search results, standard approaches for post-translational modification analysis could be applied:
Phospho-specific antibody development and validation
Mass spectrometry analysis of purified protein
Phosphatase treatment experiments to confirm modification
Site-directed mutagenesis of putative phosphorylation sites
Functional assessment of phospho-mimetic and phospho-dead mutants
These methodological approaches would help determine whether phosphorylation plays a regulatory role in bovine FRRS1 function, similar to studies conducted with other proteins in this family.
The table below summarizes key experimental findings related to FRRS1L that may guide investigations into bovine FRRS1:
| Experimental Approach | Key Findings for FRRS1L | Potential Relevance to Bovine FRRS1 |
|---|---|---|
| Co-immunoprecipitation | Interacts with GluA1 and GluA2 subunits of AMPARs | Suggests potential role in protein complexes |
| Dimerization experiments | Does not form dimers/oligomers in HEK cells | May function as monomeric protein |
| Surface localization | Partially co-localizes with GluA1 at neuronal surface | May have specific subcellular distribution |
| Vesicle association | Localizes to dynein vesicles but not kinesin5B vesicles | Potential role in specific transport mechanisms |
| CRISPR/Cas9 knockout | Reduces GluA1 expression and decreases AMPAR-mediated synaptic transmission | Critical functional role in protein expression |
| Overexpression studies | Does not change glutamatergic synaptic transmission | May function within specific concentration ranges |
Understanding these experimental findings can help guide hypothesis development and experimental design for bovine FRRS1 studies .
While the search results don't provide specific information about bovine FRRS1 mutations, FRRS1L mutations in humans are associated with epilepsy, choreoathetosis, and cognitive deficits. Experimental approaches to study mutation effects could include:
Generation of mutant constructs through site-directed mutagenesis
Expression in heterologous systems and functional comparison to wild-type
Structural studies to determine mutation effects on protein folding or interaction surfaces
Rescue experiments in knockout systems to assess functional complementation
These approaches would help determine structure-function relationships and the impact of specific mutations on bovine FRRS1 activity .
Current limitations in FRRS1 research include:
Species-specific differences in function and regulation
Limited availability of bovine-specific reagents and antibodies
Incomplete understanding of tissue-specific roles outside the nervous system
Challenges in determining precise enzymatic activities
These limitations could be addressed through:
Development of species-specific antibodies and research tools
Comparative studies across species to identify conserved and divergent functions
Application of advanced proteomics to identify comprehensive interaction networks
CRISPR/Cas9-mediated tagging of endogenous proteins to study physiological expression